search
Back to results

Personal Protective Equipment Affect Team Performance During Medical Emergencies (PPE-TEAM)

Primary Purpose

Safety Issues, Communication, Cardiopulmonary Arrest

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
WHO recommended PPE
Super-safe setup
Sponsored by
Roman Sýkora
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Safety Issues focused on measuring Personal Protective Equipment, Simulation Study, Cardiopulmonary Resuscitation, Non-Technical Skills

Eligibility Criteria

20 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) physicians
  • Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) nurses
  • Preparation and study of sent educational materials
  • Fulfillment of the whole complete simulation

Exclusion Criteria:

  • Not giving or withdrawal of the informed consent
  • Not willing to participate
  • Incomplete data acqusition

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Experimental

    Arm Label

    WHO group

    Super-safe setup

    Arm Description

    minimal setting of personal protective equipment (COVID 19) recommended by WHO

    maximal super-safe setup of personal protective equipment

    Outcomes

    Primary Outcome Measures

    The Team Emergency Assessment Measure score (TEAM score)
    The TEAM questionaire will be used and will address following items: 1) the team leader let the team know what was expected of them through direction and command, 2) the team leader maintained a global perspective, 3) the team communicated effectively, 4) the team worked together to complete tasks in a timely manner, 5) the team acted with composure and control, 6) the team morale was positive, 7)the team adapted to changing situations, 8) the team monitored and reassessed the situation, 9) the team anticipated potential actions, 10) the team prioritized tasks, 11) the team followed approved standards/guidelines and 12) the global score. The TEAM items 1 - 11 will be rated using a five-point scale (range 0-4; 0 never/hardly ever, 1 seldom, 2 about as often as not, 3 often, 4 always/nearly always). The item 12 (global score) - the overall performance will be rated on scale from 1 to 10 (best). The mean for each item will be calculated.

    Secondary Outcome Measures

    Time to first chest compression
    Time to first chest compression from the start of the scenario will be measured in seconds. Time will be obtained from the software recording of the simulator as time to first compression to reach depth at least 5cm.
    Time to first epinephrine dose administration
    The time to to first epinephrine dose administration (seconds) will be measured by observer and checked from the simulator recording.
    Time to first effective breath after reintubation
    The time to perform the first effective breath (tidal volume of at least 400ml) after reintubation will be measured in seconds . The time will be obtained from the software recording of the simulator.
    Chest compression frequency
    Average chest compression rate (per minute) will be calculated from from the software recording of the simulator. In addition, the percentage of time out of the total compression time, when the frequency of 100-120 per minute was reached, will be measured.
    Chest compression depth
    Average chest compression depth (cm) will be obtained from the software recording of the simulator. In addition, the percentage of compressions reaching a depth of 5 - 6 cm from the total number of compressions will be calculated.

    Full Information

    First Posted
    January 20, 2021
    Last Updated
    February 5, 2021
    Sponsor
    Roman Sýkora
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04742426
    Brief Title
    Personal Protective Equipment Affect Team Performance During Medical Emergencies
    Acronym
    PPE-TEAM
    Official Title
    Does the Choice of Personal Protective Equipment Affect Team Performance During Medical Emergencies? Simulation-Based Randomised Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    May 1, 2021 (Anticipated)
    Primary Completion Date
    August 31, 2021 (Anticipated)
    Study Completion Date
    September 30, 2021 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Roman Sýkora

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Safety of healthcare professionals working in high-risk environments is of upmost importance. Personal protective equipment (PPE) may affect the performance of individuals and teams by altering their senses, manual skills and ability to communicate. Current guidelines offer flexibility in terms of which specific PPE components can safely be used. Yet, in some organisations, healthcare workers become used to using PPE well above the recommended standards (termed further in text as super-safe setup, SSS). Impact of this PPE policy on team performance and in turn to patient safety is unknown. The investigators hypothesise that SSS, as compared to WHO PPE standard, would negatively impact team performance and patient outcomes in a simulated crisis scenario.
    Detailed Description
    Safety of healthcare professionals working in high-risk environments is of upmost importance. Personal protective equipment (PPE) may affect the performance of individuals and teams by altering their senses, manual skills and ability to communicate. Current guidelines (WHO, UK, ECDC) offer flexibility in terms of which specific PPE components can safely be used. Yet, in some organisations, healthcare workers become used to using PPE well above the recommended standards (termed further in text as super-safe setup, SSS). Impact of this PPE policy on team performance and in turn to patient safety is unknown. The investigators hypothesise that SSS, as compared to WHO PPE standard, would negatively impact team performance and patient outcomes in a simulated crisis scenario. Methods Design: prospective, open, randomised, controlled, parallel group trial, fully compliant with CONSORT guidelines with extension for simulation studies. Study subjects: doctors and nurses routinely working in intensive care, written prospective informed consent Setting: High-fidelity simulation centre, Third Faculty of Medicine, Charles University in Prague PPE tested WHO group (CONTROL): uses polycarbonate safety spectacles, fluid-resistant (Type IIR) surgical mask and disposable surgical gown. One pair of gloves. No head or foot cover. SSS group: Uses surgical cap, FFP3 respirator covered by surgical mask, face shield, whole-body suit (Tyvec), 3 pairs of gloves typed to suit sleeves and disposable foot cover Study procedures: Teams consisting of one doctor and two nurses will be recruited. The purpose of the study will be explained to them as a part of consent procedure, but details of evaluation and scenarios will remain undisclosed. All team members will obtain standardized educational materials focused on the solution of airway management and non-shockable rhythm of sudden circulatory arrest in a critically ill patient. Introduction to simulation centre and baseline team performance measurement: On the study day the teams will undergo a standardised introduction to simulation centre and perform a mock scenario without PPE apart from gloves and simple surgical masks. The same parameters will be measured for mock scenario as for the test scenario. Test scenario: This will be a COVID-19 patient on mechanical ventilator who suddenly loses airways and develops profound hypoxia progressing to cardiac arrest. Team will be wearing PPE according to their study group allocation at the beginning of the scenario. Outcomes: • Primary outcome: Non-technical team performance measured as TEAM score and adjusted to baseline team performance • Secondary outcomes: Quality of CPR and work according to guidelines • Exploratory qualitative objective: physiological functions of team members and self-reported confidence defined on visual analogue scale Outcome assessment methods: Performance indices will be observed by two independent, trained assessors. Both assessors will have access to video recordings of scenarios and software recordings. The final score will be an arithmetic mean of the scores of two observers. Inter-rater variability will be calculated and reported. Sample size calculation and statistics: According to [ref] the TEAM performance score was 3.3±0.7 (mean±standard deviation). Therefore, n=22 (i.e. 11 teams per group) gives 80% probability of detecting at p<0.05 (two sided) 25% difference of TEAM scores between groups. Primary outcome will be calculated by two sided Student t-test. Time-to-event outcomes will be compared using Kaplan-Meier curves and Wilcoxon test. Dissemination plan and implementation: Data will be published in a peer-reviewed journal. The results have the potential to influence hospital hygiene policies as well as choices made by individual healthcare professionals.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Safety Issues, Communication, Cardiopulmonary Arrest
    Keywords
    Personal Protective Equipment, Simulation Study, Cardiopulmonary Resuscitation, Non-Technical Skills

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    single-center, randomized (1:1), parallel-group, simulation study
    Masking
    Outcomes Assessor
    Masking Description
    Blinding of participants and researchers involved in the experiment is not possible. Only the outcome assessor and data analyst is kept blinded to the allocation of subjects.
    Allocation
    Randomized
    Enrollment
    22 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    WHO group
    Arm Type
    Active Comparator
    Arm Description
    minimal setting of personal protective equipment (COVID 19) recommended by WHO
    Arm Title
    Super-safe setup
    Arm Type
    Experimental
    Arm Description
    maximal super-safe setup of personal protective equipment
    Intervention Type
    Other
    Intervention Name(s)
    WHO recommended PPE
    Intervention Description
    Uses polycarbonate safety spectacles, fluid-resistant (Type IIR) surgical mask and disposable surgical gown. No head or foot cover.
    Intervention Type
    Other
    Intervention Name(s)
    Super-safe setup
    Intervention Description
    Uses surgical cap, FFP3 respirator covered by surgical mask, face shield, whole-body suit (Tyvec), 3 pairs of gloves typed to suit sleeves and disposable foot cover.
    Primary Outcome Measure Information:
    Title
    The Team Emergency Assessment Measure score (TEAM score)
    Description
    The TEAM questionaire will be used and will address following items: 1) the team leader let the team know what was expected of them through direction and command, 2) the team leader maintained a global perspective, 3) the team communicated effectively, 4) the team worked together to complete tasks in a timely manner, 5) the team acted with composure and control, 6) the team morale was positive, 7)the team adapted to changing situations, 8) the team monitored and reassessed the situation, 9) the team anticipated potential actions, 10) the team prioritized tasks, 11) the team followed approved standards/guidelines and 12) the global score. The TEAM items 1 - 11 will be rated using a five-point scale (range 0-4; 0 never/hardly ever, 1 seldom, 2 about as often as not, 3 often, 4 always/nearly always). The item 12 (global score) - the overall performance will be rated on scale from 1 to 10 (best). The mean for each item will be calculated.
    Time Frame
    During the intervention
    Secondary Outcome Measure Information:
    Title
    Time to first chest compression
    Description
    Time to first chest compression from the start of the scenario will be measured in seconds. Time will be obtained from the software recording of the simulator as time to first compression to reach depth at least 5cm.
    Time Frame
    During the intervention
    Title
    Time to first epinephrine dose administration
    Description
    The time to to first epinephrine dose administration (seconds) will be measured by observer and checked from the simulator recording.
    Time Frame
    During the intervention
    Title
    Time to first effective breath after reintubation
    Description
    The time to perform the first effective breath (tidal volume of at least 400ml) after reintubation will be measured in seconds . The time will be obtained from the software recording of the simulator.
    Time Frame
    During the intervention
    Title
    Chest compression frequency
    Description
    Average chest compression rate (per minute) will be calculated from from the software recording of the simulator. In addition, the percentage of time out of the total compression time, when the frequency of 100-120 per minute was reached, will be measured.
    Time Frame
    During the intervention
    Title
    Chest compression depth
    Description
    Average chest compression depth (cm) will be obtained from the software recording of the simulator. In addition, the percentage of compressions reaching a depth of 5 - 6 cm from the total number of compressions will be calculated.
    Time Frame
    During the intervention
    Other Pre-specified Outcome Measures:
    Title
    Blood pressure of team members
    Description
    Blood pressure of all the team members will be monitored in two minutes intervals throughout the simulation.
    Time Frame
    During the intervention
    Title
    Heart rate of team members
    Description
    Heart rate of all the team members will be monitored continuously throughout the simulation.
    Time Frame
    During the intervention
    Title
    Breathing frequency
    Description
    The breathing frequency will be measured in all the team members in resting condition and than continuously throughout the simulation.
    Time Frame
    During the intervention
    Title
    Body temperature of team members
    Description
    Blood temperature of all the team members will be measured in resting condition and at the end of the simulated scenario.
    Time Frame
    Immediately after the intervention
    Title
    Self assessment of the team performance
    Description
    The self assessment of the team performance by all the teams members will be obtained. The score will be evaluated by the team members from one to ten points, where ten points indicate the best possible performance.
    Time Frame
    Immediately after the intervention

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    65 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) physicians Emergency Medicine (EM) and Anesthesiology and Critical Care (ACC) nurses Preparation and study of sent educational materials Fulfillment of the whole complete simulation Exclusion Criteria: Not giving or withdrawal of the informed consent Not willing to participate Incomplete data acqusition
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Roman Sykora, PhD
    Phone
    +420602524203
    Email
    roman.sykora@lf3.cuni.cz
    First Name & Middle Initial & Last Name or Official Title & Degree
    Metodej Renza, MD
    Phone
    +420607554375
    Email
    metodej.renza@seznam.cz
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Frantisek Duska, PhD
    Organizational Affiliation
    Third Medical Faculty and FNKV University Hospital, Charles University in Prague, Czech Republic
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    All data, forms, consents and protocols will be provided on reasonable request by investigators.
    Citations:
    PubMed Identifier
    33428358
    Citation
    Mormando G, Paganini M, Alexopoulos C, Savino S, Bortoli N, Pomiato D, Graziano A, Navalesi P, Fabris F. Life-Saving Procedures Performed While Wearing CBRNe Personal Protective Equipment: A Mannequin Randomized Trial. Simul Healthc. 2021 Dec 1;16(6):e200-e205. doi: 10.1097/SIH.0000000000000540.
    Results Reference
    result
    PubMed Identifier
    20117874
    Citation
    Cooper S, Cant R, Porter J, Sellick K, Somers G, Kinsman L, Nestel D. Rating medical emergency teamwork performance: development of the Team Emergency Assessment Measure (TEAM). Resuscitation. 2010 Apr;81(4):446-52. doi: 10.1016/j.resuscitation.2009.11.027. Epub 2010 Feb 1.
    Results Reference
    result

    Learn more about this trial

    Personal Protective Equipment Affect Team Performance During Medical Emergencies

    We'll reach out to this number within 24 hrs